Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.093 AUD | -1.06% | -5.10% | +322.73% |
Apr. 30 | Nyrada's NYR-BI03 Being Studied For Potential in Traumatic Brain Injury | MT |
Apr. 18 | Transcript : Nyrada Inc., Q3 2024 Earnings Call, Apr 18, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
+322.73% | 10.95M | |
+34.00% | 704B | |
+29.29% | 577B | |
-7.75% | 348B | |
+18.53% | 327B | |
+4.95% | 288B | |
+13.79% | 234B | |
+4.93% | 198B | |
-9.78% | 194B | |
-4.89% | 147B |
- Stock Market
- Equities
- NYR Stock
- News Nyrada Inc.
- Nyrada Begins Animal Testing on NYR-BI03 Brain Injury Program